Back to Browse Journals » International Journal of High Throughput Screening » Volume 1

An overview of urinary proteomics applications in human diseases

Authors Gayathri Gopalan, Veena S Rao, Vijay V Kakkar

Published Date November 2010 Volume 2010:1 Pages 183—192

DOI http://dx.doi.org/10.2147/IJHTS.S13129

Published 18 November 2010

Gayathri Gopalan1, Veena S Rao1, Vijay V Kakkar2
1Tata Proteomics and Coagulation Unit, Thrombosis Research Institute, Bangalore, India; 2Thrombosis Research Institute, London, United Kingdom

Abstract: A major challenge in clinical proteomics is the identification of reliable biomarkers that help early diagnosis of disease, which will not only assist the clinician but also contribute to the development of personalized medicine. Urinary proteomic studies provide information on urine composition along with insight into renal physiology, kidney disease states, and other associated diseases. In the past decade, technical advances in the design of highly sensitive mass spectrometers and accurate protein quantitation technologies have led to the application of urinary proteomics in diverse research areas, including basic biomedical and clinical sciences. Of specific interest is the identification of biomarkers by virtue of improvements in instrumentation, bioinformatics, and database development. Here, we review recent discoveries in urinary proteomics with respect to identifying novel biomarker, its current challenges, and potential for future research.

Keywords: urinary proteomics, biomarker, mass spectrometry

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Application of cardiovascular disease risk prediction models and the relevance of novel biomarkers to risk stratification in Asian Indians

S Kanjilal, VS Rao, M Mukherjee, BK Natesha1, KS Renuka, et al

Vascular Health and Risk Management 2008, 4:199-211

Published Date: 6 March 2008

Readers of this article also read:

Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review

Islam MA, Firdous J, Choi YJ, Yun CH, Cho CS

International Journal of Nanomedicine 2012, 7:6077-6093

Published Date: 13 December 2012

Insight into 144 patients with ocular vascular events during VEGF antagonist injections

Mansour AM, Shahin M, Kofoed PK, Parodi MB, Shami M, Schwartz SG

Clinical Ophthalmology 2012, 6:343-363

Published Date: 6 March 2012

Plasmid-encapsulated polyethylene glycol-grafted polyethylenimine nanoparticles for gene delivery into rat mesenchymal stem cells

Chen XA, Zhang LJ, He ZJ, Wang WW, Xu B, Zhong Q, Shuai XT, Yang LQ, Deng YB

International Journal of Nanomedicine 2011, 6:843-853

Published Date: 21 April 2011

Epigenomics in cancer management

Fabricio F Costa

Cancer Management and Research 2010, 2:255-265

Published Date: 27 October 2010

Neurotransmitter testing of the urine: a comprehensive analysis

Marty Hinz, Alvin Stein, George Trachte, et al

Research and Reports in Urology 2010, 2:177-183

Published Date: 7 October 2010

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009

Inflammatory mediators: Parallels between cancer biology and stem cell therapy

A Patel, Andrew C Heinrich, Bobby Y Reddy, Pranela Rameshwar

Journal of Inflammation Research 2009, 2:13-19

Published Date: 4 February 2009